Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection

Creative Commons License

Venkatesan S., Myles P. R., Bolton K. J., Muthuri S. G., Al Khuwaitir T., Anovadiya A. P., ...Daha Fazla

JOURNAL OF INFECTIOUS DISEASES, cilt.221, sa.3, ss.356-366, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 221 Sayı: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1093/infdis/jiz152
  • Dergi Adı: JOURNAL OF INFECTIOUS DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Aquatic Science & Fisheries Abstracts (ASFA), BIOSIS, CAB Abstracts, CINAHL, EMBASE, Environment Index, MEDLINE, Public Affairs Index, Veterinary Science Database
  • Sayfa Sayıları: ss.356-366
  • Anahtar Kelimeler: Neuraminidase inhibitors, pandemic influenza, IPD meta-analysis, length of stay, antivirals, OSELTAMIVIR TREATMENT, CLINICAL-FEATURES, CHILDREN, OUTCOMES, ADULTS, COMPLICATIONS, RESISTANCE, IMPACT, COHORT, RISK
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background. The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear.